Cite
HARVARD Citation
Ali Khan, M. et al. (n.d.). Can Ribavirin be Avoided in the Management of Hepatitis C Genotype 3 Patients When Treated With Direct Acting Antivirals? A Systematic Review and Meta‐Analysis. American journal of gastroenterology. p. . [Online].